SANJEEV RAO: Open Payments
NPI 1386740074 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 24 payments from 8 companies in 2025. Trend: 2023 $269 · 2024 $162 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $110 |
| Alkermes, Inc. | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $79 |
| Neurocrine BioSciences, Inc. | 4 | $78 |
| Teva Pharmaceuticals USA, Inc. | 3 | $47 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $37 |
| Novo Nordisk Inc | 1 | $21 |
Products named: COBENFY, ARISTADA, CAPLYTA, INGREZZA, INVEGA SUSTENNA, FANAPT, UZEDY, Ozempic.
Industry payments across MO — which companies pay providers there.
